Coe Capital Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Coe Capital Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,444	Closed	-$472K	–	163
2016 Q3	$472K	Buy	4,444 +2,222	+100%	+$221K	0.15%	161
2016 Q2	$225K	Buy	+2,222	New	+$275K	0.08%	215
2014 Q4	–	Sell	-2,222	Closed	-$428K	–	284
2014 Q3	$428K	Buy	+2,222	New	+$489K	0.16%	156
2014 Q2	–	Sell	-1,667	Closed	-$426K	–	250
2014 Q1	$426K	Buy	+1,667	New	+$510K	0.12%	181

Other funds holding LUMO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Coe Capital Management's LUMO Position: Q4 2016 in Review

Coe Capital Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2016, closing a stake of 4,444 shares — an estimated $472K sold.

Coe Capital Management first reported a position in LUMO in Q1 2014 and held it in 4 quarters. The position peaked at $472K in Q3 2016. 122 funds tracked by Wall St. Rank hold LUMO as of Q4 2016.

Coe Capital Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Coe Capital Management sold 4,444 Lumos Pharma, Inc. Common Stock shares in Q4 2016, an estimated $472K.
Coe Capital Management first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2014 and held it in 4 quarters.
Coe Capital Management's Lumos Pharma, Inc. Common Stock position peaked at $472K in Q3 2016.
122 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2016.

Based on Coe Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.